title: Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications.
abstract: Advanced glycation end products (AGEs) represent a family of protein, peptide, amino acid, nucleic acid and lipid adducts formed by the reaction of carbonyl compounds derived directly or indirectly from glucose, ascorbic acid and other metabolites such as methylglyoxal. AGE formation in diabetes is of growing importance for their role as markers and potential culprits of diabetic complications, in particular retinopathy, nephropathy and neuropathy. Development of sensitive and specific assays utilizing liquid chromatography mass spectrometry with isotope dilution method has made it possible to detect and quantitate non-UV active AGEs such as carboxymethyl-lysine and glucosepane, the most prevalent AGE and protein crosslink of the extracellular matrix. Below we review studies on AGE formation in two skin biopsies obtained near the closeout of the Diabetes Control and Complications Trial (DCCT), one of which was processed in 2011 for assay of novel AGEs. The results of these analyses show that while several AGEs are associated and predict complication progression, the glucose/fructose-lysine/glucosepane AGE axis is one of the most robust markers for microvascular disease, especially retinopathy, in spite of adjustment for past or future average glycemia. Yet overall little biological and clinical information is available on glucosepane, making this review a call for data in a field of growing importance for diabetes and chronic metabolic diseases of aging.
authors.forename: Vincent M
authors.initials: VM
authors.lastname: Monnier
authors.forename: Wanjie
authors.initials: W
authors.lastname: Sun
authors.forename: David R
authors.initials: DR
authors.lastname: Sell
authors.forename: Xingjun
authors.initials: X
authors.lastname: Fan
authors.forename: Ina
authors.initials: I
authors.lastname: Nemet
authors.forename: Saul
authors.initials: S
authors.lastname: Genuth
mesh_terms: D000818:Animals; D024042:Collagen Type I / Q000737:chemistry / Q000378:metabolism; D048909:Diabetes Complications / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D017127:Glycation End Products, Advanced / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D012307:Risk Factors; D012867:Skin / Q000378:metabolism; D014652:Vascular Diseases / Q000378:metabolism / Q000473:pathology
chemical_list: D024042:Collagen Type I; D017127:Glycation End Products, Advanced; C543060:glucosepane